Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using the Pathfinder system to reduce missed abnormal cervical cytologic smear cases in a rescreening program

B M Berger1

  • 1Department of Pathology and Laboratory Medicine, Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA.

Acta Cytologica
|January 1, 1997
PubMed
Summary

The Pathfinder instrument reduced missed abnormal cervical cancer cases by 56% by standardizing screening. This quality assurance tool improved detection rates for atypical cells of undetermined significance (ASCUS).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum: Correlation between electrical impedance spectroscopy and the clinical and dermoscopic grading of actinic keratoses.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Correlation between electrical impedance spectroscopy and the clinical and dermoscopic grading of actinic keratoses.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.

The American journal of gastroenterology·2019
Same author

Quantitative structure-transformation relationships of phenylurea herbicides.

Pest management science·2001
Same author

Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.

The American journal of managed care·2000
Same author

Factors influencing transformation rates and formation of products of phenylurea herbicides in soil.

Journal of agricultural and food chemistry·1999

Area of Science:

  • Cytopathology
  • Medical Technology
  • Quality Assurance

Background:

  • Cervical cancer screening relies on accurate cytologic smear analysis.
  • False negative results in cervical cytology can lead to delayed diagnosis and treatment.
  • Process control in cytology screening is crucial for maintaining high diagnostic accuracy.

Purpose of the Study:

  • To evaluate the impact of the Pathfinder instrument on the false negative rate of cervical cytologic smears.
  • To assess the effectiveness of Pathfinder in improving the quality assurance of cervical cancer screening.

Main Methods:

  • The Pathfinder instrument was implemented in a large cytology laboratory.
  • Cytotechnologists used Pathfinder to monitor screening time, slide area, and field overlap.

Related Experiment Videos

  • A random 10% of negative cases were rescreened to determine missed abnormal cases before and after Pathfinder implementation.

    • Main Results:

    • A significant decrease in missed abnormal cervical cytologic smear cases was observed.
    • The false negative rate for atypical cells of undetermined significance (ASCUS) decreased by 56%, from 1.6% to 0.7%.
    • The study period was nine months, with a focus on ASCUS detection rates.

    Conclusions:

    • The Pathfinder system's continuous feedback and process standardization led to a reduction in missed abnormal cases.
    • The primary driver of this improvement was a marked decrease in missed ASCUS cases.
    • Pathfinder offers valuable management tools for ensuring consistent, high-quality cervical screening.